BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kung CP, Khaku S, Jennis M, Zhou Y, Murphy ME. Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res 2015;13:250-62. [PMID: 25256710 DOI: 10.1158/1541-7786.MCR-14-0385] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Vidal S, Bouzaher YH, El Motiam A, Seoane R, Rivas C. Overview of the regulation of the class IA PI3K/AKT pathway by SUMO. Semin Cell Dev Biol 2021:S1084-9521(21)00275-5. [PMID: 34753687 DOI: 10.1016/j.semcdb.2021.10.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Elabd S, Meroni G, Blattner C. TRIMming p53's anticancer activity. Oncogene 2016;35:5577-84. [PMID: 26898759 DOI: 10.1038/onc.2016.33] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
3 Valletti A, Marzano F, Pesole G, Sbisà E, Tullo A. Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer? Int J Mol Sci 2019;20:E1776. [PMID: 30974870 DOI: 10.3390/ijms20071776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
4 Gnanapradeepan K, Basu S, Barnoud T, Budina-Kolomets A, Kung CP, Murphy ME. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis. Front Endocrinol (Lausanne) 2018;9:124. [PMID: 29695998 DOI: 10.3389/fendo.2018.00124] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 15.0] [Reference Citation Analysis]
5 Cho JH, Patel B, Bonala S, Mansouri H, Manne S, Vadrevu SK, Ghouse S, Kung CP, Murphy ME, Astrinidis A, Henske EP, Kwiatkowski DJ, Markiewski MM, Karbowniczek M. The Codon 72 TP53 Polymorphism Contributes to TSC Tumorigenesis through the Notch-Nodal Axis. Mol Cancer Res 2019;17:1639-51. [PMID: 31088907 DOI: 10.1158/1541-7786.MCR-18-1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, Liu Q, George DL, Ahima RS, Murphy ME. The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Rep 2016;14:2413-25. [PMID: 26947067 DOI: 10.1016/j.celrep.2016.02.037] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 11.5] [Reference Citation Analysis]
7 Gutierrez C, Al'Khafaji AM, Brenner E, Johnson KE, Gohil SH, Lin Z, Knisbacher BA, Durrett RE, Li S, Parvin S, Biran A, Zhang W, Rassenti L, Kipps TJ, Livak KJ, Neuberg D, Letai A, Getz G, Wu CJ, Brock A. Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment. Nat Cancer 2021;2:758-72. [PMID: 34939038 DOI: 10.1038/s43018-021-00222-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 15.0] [Reference Citation Analysis]
8 Venkatachalam V, Jambhekar A, Lahav G. Reading oscillatory instructions: How cells achieve time-dependent responses to oscillating transcription factors. Curr Opin Cell Biol 2022;77:102099. [PMID: 35690043 DOI: 10.1016/j.ceb.2022.102099] [Reference Citation Analysis]
9 Leonard MK, McCorkle JR, Snyder DE, Novak M, Zhang Q, Shetty AC, Mahurkar AA, Kaetzel DM. Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma. Lab Invest 2018;98:327-38. [PMID: 29058705 DOI: 10.1038/labinvest.2017.108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
10 Chanda A, Ikeuchi Y, Karve K, Sarkar A, Chandhoke AS, Deng L, Bonni A, Bonni S. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition. Cell Death Differ 2021;28:267-82. [PMID: 32770107 DOI: 10.1038/s41418-020-0599-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kung C, Weber JD. It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy. Front Cell Dev Biol 2022;10:818744. [DOI: 10.3389/fcell.2022.818744] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Payne K, Brooks JM, Taylor GS, Batis N, Noyvert B, Pan Y, Nankivell P, Mehanna H. Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery. Cancers (Basel) 2021;13:5519. [PMID: 34771681 DOI: 10.3390/cancers13215519] [Reference Citation Analysis]
13 Feng YC, Liu XY, Teng L, Ji Q, Wu Y, Li JM, Gao W, Zhang YY, La T, Tabatabaee H, Yan XG, Jamaluddin MFB, Zhang D, Guo ST, Scott RJ, Liu T, Thorne RF, Zhang XD, Jin L. c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis. Nat Commun 2020;11:4980. [PMID: 33020477 DOI: 10.1038/s41467-020-18735-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
14 Zhang X, Pavlicev M, Jones HN, Muglia LJ. Eutherian-Specific Gene TRIML2 Attenuates Inflammation in the Evolution of Placentation. Mol Biol Evol 2020;37:507-23. [PMID: 31633784 DOI: 10.1093/molbev/msz238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Khadka P, Reitman ZJ, Lu S, Buchan G, Gionet G, Dubois F, Carvalho DM, Shih J, Zhang S, Greenwald NF, Zack T, Shapira O, Pelton K, Hartley R, Bear H, Georgis Y, Jarmale S, Melanson R, Bonanno K, Schoolcraft K, Miller PG, Condurat AL, Gonzalez EM, Qian K, Morin E, Langhnoja J, Lupien LE, Rendo V, Digiacomo J, Wang D, Zhou K, Kumbhani R, Guerra Garcia ME, Sinai CE, Becker S, Schneider R, Vogelzang J, Krug K, Goodale A, Abid T, Kalani Z, Piccioni F, Beroukhim R, Persky NS, Root DE, Carcaboso AM, Ebert BL, Fuller C, Babur O, Kieran MW, Jones C, Keshishian H, Ligon KL, Carr SA, Phoenix TN, Bandopadhayay P. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation. Nat Commun 2022;13:604. [PMID: 35105861 DOI: 10.1038/s41467-022-28198-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sabir JSM, El Omri A, Shaik NA, Banaganapalli B, Hajrah NH, Zrelli H, Arfaoui L, Awan ZA, Shaikh Omar AM, Mohammed A, Alharbi MG, Alhebshi AM, Jansen RK, Khan M. The genetic association study of TP53 polymorphisms in Saudi obese patients. Saudi J Biol Sci 2019;26:1338-43. [PMID: 31762593 DOI: 10.1016/j.sjbs.2019.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Johnson TG, Schelch K, Lai K, Marzec KA, Kennerson M, Grusch M, Reid G, Burgess A. YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms. Cancers (Basel) 2020;12:E2285. [PMID: 32823952 DOI: 10.3390/cancers12082285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Kung CP, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol 2016;231:R61-75. [PMID: 27613337 DOI: 10.1530/JOE-16-0324] [Cited by in Crossref: 77] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
19 Basu S, Murphy ME. Genetic Modifiers of the p53 Pathway. Cold Spring Harb Perspect Med 2016;6:a026302. [PMID: 27037420 DOI: 10.1101/cshperspect.a026302] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
20 Gu J, Zhang S, He X, Chen S, Wang Y. High expression of PIG11 correlates with poor prognosis in gastric cancer. Exp Ther Med 2021;21:249. [PMID: 33603857 DOI: 10.3892/etm.2021.9680] [Reference Citation Analysis]
21 Basu S, Barnoud T, Kung CP, Reiss M, Murphy ME. The African-specific S47 polymorphism of p53 alters chemosensitivity. Cell Cycle 2016;15:2557-60. [PMID: 27484708 DOI: 10.1080/15384101.2016.1215390] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
22 Liu J, Zhang C, Wang X, Hu W, Feng Z. Tumor suppressor p53 cross-talks with TRIM family proteins. Genes Dis 2021;8:463-74. [PMID: 34179310 DOI: 10.1016/j.gendis.2020.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Kung CP, Liu Q, Murphy ME. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation. Cancer Biol Ther 2017;18:484-91. [PMID: 28475405 DOI: 10.1080/15384047.2017.1323595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
24 Skhoun H, Khattab M, Belkhayat A, Takki Chebihi Z, Bakri Y, Dakka N, El Baghdadi J. Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children. Mol Biol Rep 2022. [PMID: 35705773 DOI: 10.1007/s11033-022-07643-3] [Reference Citation Analysis]
25 Feng YC, Zhao XH, Teng L, Thorne RF, Jin L, Zhang XD. The pan-cancer lncRNA MILIP links c-Myc to p53 repression. Mol Cell Oncol 2020;8:1842714. [PMID: 33553602 DOI: 10.1080/23723556.2020.1842714] [Reference Citation Analysis]
26 Shi X, Du Y, Li S, Wu H. The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells. Int J Mol Sci 2022;23:3639. [PMID: 35408996 DOI: 10.3390/ijms23073639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sawosz E, Jaworski S, Kutwin M, Vadalasetty KP, Grodzik M, Wierzbicki M, Kurantowicz N, Strojny B, Hotowy A, Lipińska L, Jagiełło J, Chwalibog A. Graphene Functionalized with Arginine Decreases the Development of Glioblastoma Multiforme Tumor in a Gene-Dependent Manner. Int J Mol Sci 2015;16:25214-33. [PMID: 26512645 DOI: 10.3390/ijms161025214] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
28 Song X, Zhang C, Liu Z, Liu Q, He K, Yu Z. Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer. PeerJ 2019;7:e7522. [PMID: 31565554 DOI: 10.7717/peerj.7522] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 De Souza C, Madden JA, Minn D, Kumar VE, Montoya DJ, Nambiar R, Zhu Z, Xiao WW, Tahmassebi N, Kathi H, Nelson N, Karnezis AN, Chien J. The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression. Int J Mol Sci 2020;21:E8025. [PMID: 33126568 DOI: 10.3390/ijms21218025] [Reference Citation Analysis]
30 Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, Morrione A, Giordano A, Cenciarelli C. p53 signaling in cancer progression and therapy. Cancer Cell Int 2021;21:703. [PMID: 34952583 DOI: 10.1186/s12935-021-02396-8] [Reference Citation Analysis]
31 Kim BY, Lee SY, Chung SK. Differential Transcriptional Regulation of Polymorphic p53 Codon 72 in Metabolic Pathways. Int J Mol Sci 2021;22:10793. [PMID: 34639134 DOI: 10.3390/ijms221910793] [Reference Citation Analysis]
32 Tutton S, Azzam GA, Stong N, Vladimirova O, Wiedmer A, Monteith JA, Beishline K, Wang Z, Deng Z, Riethman H, McMahon SB, Murphy M, Lieberman PM. Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres. EMBO J 2016;35:193-207. [PMID: 26658110 DOI: 10.15252/embj.201490880] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
33 Gunaratna RT, Santos A, Luo L, Nagi C, Lambertz I, Spier M, Conti CJ, Fuchs-Young RS. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model. Oncogene 2019;38:3535-50. [PMID: 30651598 DOI: 10.1038/s41388-018-0630-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
34 Molina-Olvera G, Rivas-Ortiz CI, Schcolnik-Cabrera A, Castillo-Rodal AI, López-Vidal Y. RNA Microarray-Based Comparison of Innate Immune Phenotypes between Human THP-1 Macrophages Stimulated with Two BCG Strains. Int J Mol Sci 2022;23:4525. [PMID: 35562916 DOI: 10.3390/ijms23094525] [Reference Citation Analysis]
35 Lara-ureña N, Jafari V, García-domínguez M. Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases. IJMS 2022;23:8012. [DOI: 10.3390/ijms23148012] [Reference Citation Analysis]